359 related articles for article (PubMed ID: 29131812)
1. An improved distance-to-dose correlation for predicting bladder and rectum dose-volumes in knowledge-based VMAT planning for prostate cancer.
Wall PDH; Carver RL; Fontenot JD
Phys Med Biol; 2018 Jan; 63(1):015035. PubMed ID: 29131812
[TBL] [Abstract][Full Text] [Related]
2. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
[TBL] [Abstract][Full Text] [Related]
3. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
Devlin L; Dodds D; Sadozye A; McLoone P; MacLeod N; Lamb C; Currie S; Thomson S; Duffton A
Br J Radiol; 2020 Apr; 93(1108):20190789. PubMed ID: 31971829
[TBL] [Abstract][Full Text] [Related]
5. Impact of database quality in knowledge-based treatment planning for prostate cancer.
Wall PDH; Carver RL; Fontenot JD
Pract Radiat Oncol; 2018; 8(6):437-444. PubMed ID: 29730280
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
[TBL] [Abstract][Full Text] [Related]
7. Biological optimization in volumetric modulated arc radiotherapy for prostate carcinoma.
Mihaylov IB; Fatyga M; Bzdusek K; Gardner K; Moros EG
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1292-8. PubMed ID: 21570214
[TBL] [Abstract][Full Text] [Related]
8. Predicting liver SBRT eligibility and plan quality for VMAT and 4π plans.
Tran A; Woods K; Nguyen D; Yu VY; Niu T; Cao M; Lee P; Sheng K
Radiat Oncol; 2017 Apr; 12(1):70. PubMed ID: 28438215
[TBL] [Abstract][Full Text] [Related]
9. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
[TBL] [Abstract][Full Text] [Related]
10. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.
Jiao SX; Wang ML; Chen LX; Liu XW
Sci Rep; 2021 Feb; 11(1):3117. PubMed ID: 33542427
[TBL] [Abstract][Full Text] [Related]
15. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.
Casares-Magaz O; Moiseenko V; Hopper A; Pettersson NJ; Thor M; Knopp R; Deasy JO; Muren LP; Einck J
Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808
[TBL] [Abstract][Full Text] [Related]
16. Application of aSi-kVCBCT for Volume Assessment and Dose Estimation: An Offline Adaptive Study for Prostate Radiotherapy.
Gandhi A; Vellaiyan S; Subramanian S; Swamy ST; Subramanian K; Ayyalusamy A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):229-234. PubMed ID: 30678437
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of biological versus physical optimization for single-arc VMAT for prostate and head and neck cases.
Pyshniak V; Fotina I; Zverava A; Siamkouski S; Zayats E; Kopanitsa G; Okuntsau D
J Appl Clin Med Phys; 2014 Jul; 15(4):4514. PubMed ID: 25207394
[TBL] [Abstract][Full Text] [Related]
18. Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.
Murthy V; Shukla P; Adurkar P; Master Z; Mahantshetty U; Shrivastava S
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):119-24. PubMed ID: 22300567
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
20. A simple algorithm to predict non-compliance with organ at risk dose-volume constraints when planning intensity modulated post-prostatectomy radiation treatment: 'Why we should put the CART before the horse'.
Collier N; Kneebone A; Hruby G; McCloud P; Booth J; Eade T
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):546-551. PubMed ID: 31136089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
